The usage survey of phosphate binder for CKD-MBD in western Saitama hemodialysis facilities.
Not Applicable
- Conditions
- CKD-MBD in hemodialysis patients
- Registration Number
- JPRN-UMIN000022935
- Lead Sponsor
- Saitama Medical University
- Brief Summary
The median serum phosphorus, corrected calcium and intact PTH for April 2015 were 5.4 mg / dL, 9.1 mg / dL and 147 pg / dL, respectively. In addition,more PB types were significantly correlated with higher serum phosphorus levels (p < 0.001). Compared with other agents, significant change was observed only in FeC group, and serum phosphorus decreased by 0.6 mg / dL (N = 39, p = 0.006). Furthermore, in the same group, hemoglobin increased from 10.4 mg / dL to 11.4 mg / dL (p = 0.002).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1373
Inclusion Criteria
Not provided
Exclusion Criteria
Nothing
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The achievement rate of serum phosphate value.
- Secondary Outcome Measures
Name Time Method